FindTrial
Sign In

Randomized controlled trial of uterine cavity infusion of G-CSF for unexplained recurrent implantation failure

Randomized controlled trial of uterine cavity infusion of G-CSF for unexplained recurrent implantation failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16007910
Enrollment
Unknown
Registered
2016-02-08
Start date
2016-01-25
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent implantation failure

Interventions

treatment group:intrauterine infusion of G-CSF
control group:none

Sponsors

Peking University third hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. selected patients who were in accordance with the definition of RIF and were younger than 40 years of age; 2. screening patients with unknown causes in these patients to enter the group (need to be screened for a combination of easy to plug, autoimmune antibodies, thyroid function, chromosome, hysteroscopy); 3. the specific cause of the RIF patient after treatment has not yet implanted into the group.

Exclusion criteria

Exclusion criteria: patients with kidney disease, sickle cell anemia, chronic neutropenia, malignant tumors.

Design outcomes

Primary

MeasureTime frame
Implantation rate;—

Countries

China

Contacts

Public ContactHaiyan Wang
wangquan1991@sina.com+86 13661319838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026